JNJ stock icon

Johnson & Johnson
JNJ

$152.35
1.23%

Market Cap: 367B

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 27 analysts
0
News positive %
of 91 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

19% more call options, than puts

Call options by funds: $2.68B | Put options by funds: $2.25B

0% less capital invested

Capital invested by funds: $263B [Q4 2023] → $261B (-$1.16B) [Q1 2024]

0.71% less ownership

Funds ownership: 60.89% [Q4 2023] → 60.18% (-0.71%) [Q1 2024]

1% less funds holding

Funds holding: 3,758 [Q4 2023] → 3,711 (-47) [Q1 2024]

10% less repeat investments, than reductions

Existing positions increased: 1,515 | Existing positions reduced: 1,688

23% less first-time investments, than exits

New positions opened: 154 | Existing positions closed: 201

31% less funds holding in top 10

Funds holding in top 10: 288 [Q4 2023] → 199 (-89) [Q1 2024]

Research analyst outlook

27 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$150
2%
downside
Avg. target
$189
24%
upside
High target
$215
41%
upside

27 analyst ratings

21 positive
78%
neutral
22%
negative
0%
Daiwa Capital
Narumi Nakagiri
2%downside
$150
Neutral
Downgraded
23 Jul 2024
Goldman Sachs
Chris Shibutani
2%upside
$155
Neutral
Maintained
19 Jul 2024
TD Cowen
Joshua Jennings
21%upside
$185
Buy
Maintained
18 Jul 2024
RBC Capital
Shagun Singh
15%upside
$175
Outperform
Reiterated
18 Jul 2024
Morgan Stanley
Terence Flynn
11%upside
$169
Equal-Weight
Maintained
18 Jul 2024

Financial journalist opinion

Based on 91 articles about JNJ published over the past 30 days